Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | £1 | £0 | £0 | £0 |
| % Growth | 438.2% | 14.4% | 984.6% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £1 | £0 | £0 | -£0 |
| % Margin | 99.3% | 92% | 90.7% | -35.6% |
| R&D Expenses | £2 | £3 | £2 | £3 |
| G&A Expenses | £8 | £8 | £6 | £7 |
| SG&A Expenses | £6 | £5 | £4 | £3 |
| Sales & Mktg Exp. | -£0 | -£3 | -£2 | -£3 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £7 | £8 | £6 | £7 |
| Operating Income | -£7 | -£8 | -£6 | -£7 |
| % Margin | -790.1% | -5,104.4% | -4,764.7% | -52,638.3% |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | -£6 | -£8 | -£6 | -£6 |
| Tax Expense | -£1 | -£1 | -£1 | -£1 |
| Net Income | -£6 | -£7 | -£5 | -£5 |
| % Margin | -680.3% | -4,209.5% | -3,954.4% | -43,462.5% |
| EPS | -0.062 | -0.093 | -0.089 | -0.12 |
| % Growth | 32.6% | -3.8% | 25.7% | – |
| EPS Diluted | -0.062 | -0.093 | -0.089 | -0.12 |
| Weighted Avg Shares Out | 91 | 70 | 60 | 45 |
| Weighted Avg Shares Out Dil | 91 | 70 | 60 | 45 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£7 | -£8 | -£6 | -£7 |
| % Margin | -789.3% | -5,025.3% | -4,646.8% | -52,495% |